EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study

Fleur H J Kaptein, Noori A M Guman iD, Susan B Lohle, Frederikus A Klok iD, Albert T A Mairuhu, Pieter W Kamphuisen, Nick Van Es, Menno V Huisman

TH Open · 2024-01 · 08 (01) · e61-e71

DOI: 10.1055/a-2214-8101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TH Open, online erschienen am 30.01.2024. Verfasst von Fleur H J Kaptein und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LEO Pharma, Pfizer, Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current guidelines recommend either low-molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs) as first-line treatment in cancer-associated venous thromboembolism (VTE).

Aim

This study aimed to investigate treatment regimens for cancer-associated VTE over the past 5 years, explore predictors for initial treatment (LMWH vs. DOAC), and to assess the risks of recurrent VTE and bleeding.

Methods

This was a Dutch, multicenter, retrospective cohort study including consecutive patients with cancer-associated VTE between 2017 and 2021. Treatment predictors were assessed with multivariable logistic regression models. Six-month cumulative incidences for recurrent VTE and major bleeding (MB) were estimated with death as competing risk.

Results

In total, 1,215 patients were included. The majority (1,134/1,192; 95%) started VTE treatment with anticoagulation: 561 LMWH (47%), 510 DOACs (43%), 27 vitamin K antagonist (2.3%), and 36 other/unknown type (3.0%). The proportion of patients primarily treated with DOACs increased from 18% (95% confidence interval [CI] 12–25) in 2017 to 70% (95% CI 62–78) in 2021. Poor performance status (adjusted odds ratio [aOR] 0.72, 95% CI 0.53–0.99) and distant metastases (aOR 0.61, 95% CI 0.45–0.82) were associated with primary treatment with LMWH. Total 6-month cumulative incidences were 6.0% (95% CI 4.8–7.5) for recurrent VTE and 7.0% (95% CI 5.7–8.6) for MB. During follow-up, 182 patients (15%) switched from LMWH to a DOAC, and 54 patients (4.4%) vice versa, for various reasons, including patient preference, recurrent thrombosis, and/or bleeding.

Conclusion

DOAC use in cancer-associated VTE has increased rapidly over the past years. Changes in anticoagulation regimen were frequent over time, and were often related to recurrent thrombotic and bleeding complications, illustrating the complexity and challenges of managing cancer-associated VTE.

Schlagwörter

Stichwörter der Autor:innen

anticoagulantscohort studieshemorrhageneoplasmsvenous thromboembolism

Autor:innen und Institutionen

  • Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Vascular Medicine, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Pulmonary Hypertension and Thrombosis, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Department of Internal Medicine, Tergooi Medical Center, Hilversum, the Netherlands.
  • Department of Internal Medicine, Haga Hospital, The Hague, the Netherlands.

ORCID-Profile: Noori A M Guman, Frederikus A Klok

Förderung

  • LEO Pharma
  • Pfizer
  • Bayer

Zitieren

APA

Kaptein, F. H. J., Guman, N. A. M., Lohle, S. B., Klok, F. A., Mairuhu, A. T. A., Kamphuisen, P. W., Es, N. V., & Huisman, M. V. (2024). Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study. TH Open, 08(01), e61-e71. https://doi.org/10.1055/a-2214-8101

Vancouver

Kaptein FHJ, Guman NAM, Lohle SB, Klok FA, Mairuhu ATA, Kamphuisen PW, et al. Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study. TH Open. 2024;08(01):e61-e71. doi:10.1055/a-2214-8101

BibTeX
@article{Kaptein2024,
  author = {Kaptein, Fleur H J and Guman, Noori A M and Lohle, Susan B and Klok, Frederikus A and Mairuhu, Albert T A and Kamphuisen, Pieter W and Es, Nick Van and Huisman, Menno V},
  title = {Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study},
  journal = {TH Open},
  year = {2024},
  volume = {08},
  number = {01},
  pages = {e61--e71},
  doi = {10.1055/a-2214-8101}
}
Kostenlos starten →